Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany
P. Jungberg, Uwe Totzke, Marcel Reiser, Jan Knoblich et al.
Journal
Supportive Care in Cancer
Topics
Neutropenia and Cancer Infections
article
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany
P. Jungberg, Uwe Totzke, Marcel Reiser, Jan Knoblich, T. Steinmetz, Dagmar Guth, Katharina Bernhardt, Thomas Fietz, Thomas Göhler
article en
Abstract
No abstract available for this paper.
Publication Tag
Supportive Care in CancerVol. 34(2)
Institutions
Chemnitz University of Technology (DE), Kliniken des Landkreises Lörrach (DE), Hegau-Bodensee-Klinikum Singen (DE), Praxis für Hämatologie und Onkologie (DE), Accord Healthcare (Poland) (PL), University Hospital Cologne (DE), Helios Vogtland Klinikum Plauen (DE), Georg Fischer (Switzerland) (CH), Klinikum Chemnitz (DE), Freie Universität Berlin (DE), Technische Universität Dresden (DE)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany — P. Jungberg, Uwe Totzke, et al. · Supportive Care in Cancer (2026) | TGRS Research Map | TGRS